Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Diabetic“
Suchtreffer
Begriffe & Kennungen
Diabetische Neuropathien
Eintrag öffnenDiabetische Retinopathie
Eintrag öffnenDiabetischer Fuß
Eintrag öffnenDiabetisches Koma
Eintrag öffnenDuloxetine Lilly · 4.8 · In the 12 week acute phase of three clinical trials of duloxetine in patients with diabetic neuropathic pain,
Eintrag öffnenDuloxetine Viatris (previously Duloxetine Mylan) · 4.8 · In the 12 week acute phase of three clinical trials of duloxetine in patients with diabetic neuropathic pain,
Eintrag öffnenDuloxetine Zentiva · 4.8 · In the 12 week acute phase of three clinical trials of duloxetine in patients with diabetic neuropathic pain,
Eintrag öffnenDuoTrav · 4.5 · Beta blockers may increase the hypoglycaemic effect of antidiabetic medicinal products. Beta blockers can mask
Eintrag öffnenEbymect · 4.8 · Diabetic ketoacidosis In the DECLARE study, with a median exposure time of 48 months, events of DKA were repor
Eintrag öffnenEdistride · 4.8 · Diabetic ketoacidosis in type 2 diabetes mellitus In the DECLARE study, with a median exposure time of 48 mont
Eintrag öffnenEdurant · 4.5 · (inhibition of intestinal P-gp) ANTIDIABETICS Metformin* metformin AUC ↔ No dose adjustment is required. 850 m
Eintrag öffnenEdurant · 4.5 · (inhibition of intestinal P-gp) ANTIDIABETICS Metformin* metformin AUC ↔ No dose adjustment is required. 850 m
Eintrag öffnenEmcitate · 4.5 · Anti-diabetic agents Tiratricol may reduce blood glucose levels. The dose of anti-diabetic agents may need to
Eintrag öffnenEucreas · 4.5 · As with other oral antidiabetic medicinal products the hypoglycaemic effect of vildagliptin may be reduced by
Eintrag öffnenEucreas · 4.5 · Results from clinical trials conducted with the oral antidiabetics pioglitazone, metformin and glyburide in co
Eintrag öffnenEviplera · 4.5 · Tenofovir: AUC: ↔ Cmax: ↔ Cmin: N/A ANTIDIABETICS Metformin/Emtricitabine Interaction not studied. No dose adj
Eintrag öffnenFiasp · 4.5 · The following substances may reduce insulin requirement: Oral antidiabetics, monoamine oxidase inhibitors (MAO
Eintrag öffnenForxiga · 4.8 · Diabetic ketoacidosis in type 2 diabetes mellitus In the DECLARE study, with a median exposure time of 48 mont
Eintrag öffnenGalvus · 4.5 · As with other oral antidiabetic medicinal products the hypoglycaemic effect of vildagliptin may be reduced by
Eintrag öffnenGalvus · 4.5 · Results from studies conducted with these oral antidiabetics have shown no clinically relevant pharmacokinetic
Eintrag öffnen